Or they have the risk of having new thrombi or suffer from bleedings. This is the dilemma that doctors have to face every time they administer an anticoagulant treatment to patients with venous thromboembolic disease (VTE).
So far, experts considered that risks between men and women in this situation barely differed. However, a study done by the investigators of the Computerized Registry of Patients with Venous Thromboembolism (RIETE) has recently reported a new finding. Women actually bear the brunt: they bleed more than men and their mortality is higher. On the contrary, the chances they have of having another venous thrombosis are lower than in men.
The study, led by Dr. Ángeles Blanco-Molina, head of section of Internal Medicine of Reina Sofía Hospital (Córdoba) observed the parameters of 47.499 patients, of whom 51% (24.280) were women, during 253 days under anticoagulant treatment.
Authors base their conclusions to the fact that, in general, analysed patients are older and they usually show more immobilization. These situations actually worsen VTE prognosis.
Moreover, doses of anticoagulant treatment in women were higher to the ones used in men, probably because a same dose in bodies of different weight (women usually weight lower than men) leads to higher concentrations, and contributes to bleedings.
To find out how much you know about the VTE we have made a little quiz. Are you ready?
Barcelona hosted the 7th International Symposium to be on Women’s Health Issues in Thrombosis and Haemostasis (WHITH), a meeting on new findings in women’s health related to VTE
As indicated by one of the studies presented during the 14th Venous Thromboembolism Forum
Hospital Ramón y Cajal of Madrid is the first Spanish centre to activate the PE Code
Advances presented at the second edition of the International RIETE Meeting